...
首页> 外文期刊>Parasitology Research >Strongyloides stercoralis: detection of parasite-derived DNA in serum samples obtained from immunosuppressed patients
【24h】

Strongyloides stercoralis: detection of parasite-derived DNA in serum samples obtained from immunosuppressed patients

机译:Strotyloides Stercoralis:检测从免疫抑制患者获得的血清样品中的寄生虫衍生的DNA

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Strongyloidiasis is an important neglected disease, which is life threatening in immunocompromised patients. This study aimed to evaluate the frequency of Strongyloides stercoralis infection among immunosuppressed subjects living in endemic communities by conventional PCR of the 18S rRNA and Cox1 genes to detect cell-free DNA in the patients' serum samples. Fresh stool and serum samples were obtained from participants. The stool samples were examined using parasitological methods. Total DNA was extracted from the serum samples and S. stercoralis larvae isolated from patient fecal samples. Conventional PCR to amplify a 101 bp fragment of the 18S rRNA gene was carried out for all extracted DNA, and then positive samples were further evaluated for a 121 bp fragment of the Cox1 gene. The PCR products of selected samples were sequenced and BLAST analysis was performed. Out of 120 patients, 57 and 63 cases had autoimmune disorders and cancer, respectively. The 101 bp fragments of the 18S rRNA were successfully amplified in 36 out of 120 (30%) serum samples. The PCR products of five samples were sequenced and compared with reference sequences in GenBank, which showed 97% identity and 90% coverage. In conclusion, to the best of our knowledge, this is the first molecular study for the detection of S. stercoralis cell-free DNA in human serum samples. These results provide useful insights for future studies and show that serum is an alternative specimen and may be useful in molecular diagnosis of diseases, particularly in immunosuppressive patients.
机译:强肌腱病是一种重要的被忽视的疾病,其在免疫功能性患者中威胁。本研究旨在通过常规PCR评估18S rRNA和COX1基因的常规PCR在患者血清样品中检测无细胞群中的免疫抑制受试者的抗免疫抑制受试者的频率。从参与者获得新鲜粪便和血清样品。使用寄生管学方法检查粪便样品。从血清样品和患者粪便样品中分离的血清样品和S. Stercoralis幼虫提取总DNA。对于所有提取的DNA进行常规PCR扩增18S rRNA基因的101bp片段,然后进一步评价阳性样品的COX1基因的121bp片段。测序所选样品的PCR产物并进行喷射分析。在120例患者中,57例和63例分别具有自身免疫性疾病和癌症。 18S rRNA的101bp片段在120(30%)血清样品中的36个中成功扩增。测序五个样品的PCR产物,并与Genbank中的参考序列进行比较,其显示出97%的同一性和90%的覆盖率。总之,据我们所知,这是第一个用于检测人血清样品中的S.Stercoralis细胞DNA的分子研究。这些结果为未来的研究提供了有用的见解,并表明血清是一种替代标本,可用于分子诊断疾病,特别是在免疫抑制患者中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号